| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3193245 | Annals of Allergy, Asthma & Immunology | 2007 | 13 Pages |
Abstract
With no clear consensus on corticosteroid-sparing treatment in corticosteroid-dependent asthmatic patients, systemic glucocorticoids remain the foremost therapy, with adverse effects that require monitoring and prophylaxis.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Inderpal MD, William B. MD,